Evidence map›Paper›PMID 25922519›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

IRBIT regulates CaMKIIα activity and contributes to catecholamine homeostasis through tyrosine hydroxylase phosphorylation.

Katsuhiro Kawaai, Akihiro Mizutani, Hirotaka Shoji, Naoko Ogawa, Etsuko Ebisui, Yukiko Kuroda, Shigeharu Wakana, Tsuyoshi Miyakawa, Chihiro Hisatsune, Katsuhiko Mikoshiba

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Regulation of the intestinal NaAmerican journal of physiology. Cell physiology · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Calmodulin and Its Binding Proteins in Parkinson's Disease.International journal of molecular sciences · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Depotentiation depends on IPLearning & memory (Cold Spring Harbor, N.Y.) · 2020
    Article
  14. Article
  15. Article
  16. Review
  17. Modulation of ClScience signaling · 2018
    Article
  18. Article
  19. Splicing variation of Long-IRBIT determines the target selectivity of IRBIT family proteins.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Katsuhiro KawaaiLaboratory for Developmental Neurobiology, Brain Science Institute, RIKEN, Wako, Saitama 351-0198, Japan;
Akihiro MizutaniDepartment of Pharmacotherapeutics, Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan;
Hirotaka ShojiDivision of Systems Medical Science, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan;
Naoko OgawaLaboratory for Developmental Neurobiology, Brain Science Institute, RIKEN, Wako, Saitama 351-0198, Japan;
Etsuko EbisuiLaboratory for Developmental Neurobiology, Brain Science Institute, RIKEN, Wako, Saitama 351-0198, Japan;
Yukiko KurodaLaboratory of Cell and Tissue Biology, Keio University School of Medicine, Tokyo 160-8582, Japan; and.
Shigeharu WakanaTechnology and Development Team for Mouse Phenotype Analysis, BioResource Center, RIKEN, Tsukuba, Ibaraki 305-0074, Japan.
Tsuyoshi MiyakawaDivision of Systems Medical Science, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan;ORCID http://orcid.org/0000-0003-0137-8200
Chihiro HisatsuneLaboratory for Developmental Neurobiology, Brain Science Institute, RIKEN, Wako, Saitama 351-0198, Japan;
Katsuhiko MikoshibaLaboratory for Developmental Neurobiology, Brain Science Institute, RIKEN, Wako, Saitama 351-0198, Japan; mikosiba@brain.riken.jp.
RIKEN Center for Brain Science · JPFujita Health University · JPKeio University · JPRIKEN BioResource Research Center · JPShowa Pharmaceutical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inositol 1,4,5-trisphosphate receptor (IP3R) binding protein released with IP3 (IRBIT) contributes to various physiological events (electrolyte transport and fluid secretion, mRNA polyadenylation, and the maintenance of genomic integrity) through its interaction with multiple targets. However, little is known about the physiological role of IRBIT in the brain. Here we identified calcium calmodulin-dependent kinase II alpha (CaMKIIα) as an IRBIT-interacting molecule in the central nervous system. IRBIT binds to and suppresses CaMKIIα kinase activity by inhibiting the binding of calmodulin to CaMKIIα. In addition, we show that mice lacking IRBIT present with elevated catecholamine levels, increased locomotor activity, and social abnormalities. The level of tyrosine hydroxylase (TH) phosphorylation by CaMKIIα, which affects TH activity, was significantly increased in the ventral tegmental area of IRBIT-deficient mice. We concluded that IRBIT suppresses CaMKIIα activity and contributes to catecholamine homeostasis through TH phosphorylation.

Indexed as

AdenosylhomocysteinaseAnimalsBrainCalcium-Calmodulin-Dependent Protein Kinase Type 2CatecholaminesHEK293 CellsHomeostasisHumansMiceMice, KnockoutPhosphorylationTyrosine 3-MonooxygenaseAdenosylhomocysteinaseCalcium-Calmodulin-Dependent Protein Kinase Type 2Camk2a protein, mouseCatecholaminesIRBIT protein, mouseTyrosine 3-MonooxygenaseCaMKIIαcatecholaminehyperactivityIRBIT

Identifiers

PMID25922519
PMCPMC4418850
OpenAlexW2068823479

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.